Government to End Medicine Shortages Through State-Backed Pharmaceutical Corporation

The Maldives government is leveraging its newly established State Pharmaceutical and Medical Supply Corporation Limited to tackle persistent medicine shortages and regulate soaring prices across the archipelago. Minister of Health, Family, and Welfare Geela Alic stated that strengthening the state-backed company is central to ensuring patients have reliable access to essential treatments. Currently, the Maldives relies on a fragmented supply chain where the State Trading Organisation (STO) provides 30 percent of required medicines, while the private sector handles the remaining 70 percent. Minister Alic explained that because the national demand for specific drugs is relatively small, having multiple importers compete for the same products is inefficient and often leads to instability in supply. To resolve this, the government aims to consolidate the import process through a limited number of parties. The Minister noted that the current system relies on specific registered parties holding exclusive agreements with suppliers. By expanding these agreements and utilizing the state pharmaceutical company, the government intends to diversify suppliers and secure larger, more consistent quantities of medication. Beyond availability, the government is focusing on affordability. Minister Alic revealed that the state company is collaborating with neighboring countries to stabilize prices and prevent excessive profit margins. In tandem, efforts are underway through Aasandha, the national health insurance scheme, to establish minimum retail prices and regulate overall costs. These reforms come in response to widespread public frustration. Patients in both the capital, Malé, and the outer atolls have frequently reported stockouts of essential medicines, forcing them to use substitutes or pay inflated prices. Concerns over medication quality have also persisted. Founded in 2025, the state pharmaceutical company has already begun importing its initial shipments to the local market. The government believes that by enhancing the capacity of this entity and improving the reach of STO pharmacies across the atolls, the country can finally move toward a sustainable and patient-centered healthcare supply chain.